Device Electrophysiology

Sensitherm Multi

Payments companies reported to CMS as associated with Sensitherm Multi. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$3,215associated payments (2023-2025)
96clinicians with associated payments
1company reporting

By year

2024 $2,885
2025 $330

Payments reported as associated with Sensitherm Multi, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Clinical Cardiac Electrophysiology $2,099
Cardiovascular Disease $275
Internal Medicine $162
Gastroenterology (Internal Medicine) $145
Physician Assistant $107
Family $97.09

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Sensitherm Multi

These are the largest totals companies reported as associated with Sensitherm Multi. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Ismael Valle Irizarry San German, PR Clinical Cardiac Electrophysiology $152.52
Javier Mirabal Arroyo Bayamon, PR Clinical Cardiac Electrophysiology $150.73
Joshua Leichman Reno, NV Clinical Cardiac Electrophysiology $145.88
Suleyka Olivero-Rivera Bayamon, PR Clinical Cardiac Electrophysiology $145.44
Veronica Zayas-Torres Dallas, TX Internal Medicine $145.43
Angel Morales-Santiago Snellville, GA Gastroenterology (Internal Medicine) $145.43
Omid Yousefian Santa Barbara, CA Cardiovascular Disease $125.50
John Summers Oklahoma City, OK Clinical Cardiac Electrophysiology $91.03
Andrew Brenyo Rock Hill, SC Clinical Cardiac Electrophysiology $85.70
Eric Braunstein Los Angeles, CA Clinical Cardiac Electrophysiology $58.71

Prescribed Sensitherm Multi?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.